NAP1L1P1

Across TCGA pan-cancer cohorts, NAP1L1P1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated NAP1L1P1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher NAP1L1P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NAP1L1P1 expression acts as an unfavorable survival marker, although some lineages such as UCS and LGG show a favorable association.

KIRP, UCS, and ACC are the cancer types where NAP1L1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.852	0.959	<.001	140	view →
UCS	DFS	Median	II,III,IV	0.631	0.244	<.001	108	view →
ACC	DFS	Median	All	0.385	0.768	<.001	92	view →
LIHC	OS	Median	All	0.605	0.765	<.001	63	view →
MESO	OS	Median	All	0.451	0.648	.003	47	view →
LGG	DFS	Median	All	0.817	0.656	<.001	38	view →
STAD	DFS	Quartile	All	0.228	0.503	.007	30	view →
UCEC	DFS	Tertile	All	0.620	0.841	.002	18	view →
LUSC	DFS	Median	III,IV	0.236	0.754	.004	17	view →
KIRC	DFS	Quartile	IV	0.393	0.653	.019	12	view →
SKCM	OS	Median	III,IV	0.465	0.322	.018	10	view →
KICH	OS	Quartile	II,III,IV	0.562	1.000	.035	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

NAP1L1P1–KIRP (DFS)

Open the KIRP breakdown →